Search

Paul W Zinke

from Fort Worth, TX
Age ~66
Get Report
Also known as:
Paul William Zinke, Paul William Albirta, William P Zinke
Phone and address:
4129 Willow Way Rd, Fort Worth, TX 76133
(817) 292-3593
Related to:
Christopher R Mcgeady, 45John C Mcbride, 78Wanda ZinkeJaime Mcgeady, 39
Connected to:
Angela Zinke, 47Chris V Zinke, 59Daryn L Zinke, 59Megan E Zinke, 29Otto H Zinke, 69Stefanie M Zinke, 41Tucker P Zinke, 55Joseph C Zinker, 91Joshua R Zinker, 53Chris Zinkhan, 67

Paul Zinke Phones & Addresses

  • 4129 Willow Way Rd, Fort Worth, TX 76133 (817) 292-3593
  • Austin, TX
  • 706 Winifred Dr, Garland, TX 75041
  • Grapevine, TX

Work

Company: Novartis institutes for biomedical research (nibr) Jan 1999 Position: Principal scientist, global discovery chemistry

Education

Degree: Master of Science, Masters School / High School: Texas A&M University - Commerce Specialities: Chemistry

Skills

Drug Discovery • Lead Change • Medicinal Chemistry • Drug Development • Drug Design • Pharmaceutical Industry • Adme • Hplc • Chemistry • Organic Chemistry • Organic Synthesis • Glp • Gmp • Safety • Process Chemistry • Teaching • Sop • Purification • Nmr • Uv/Vis • Assay Development • Organometallic Chemistry • Cell • Lead Generation • Ocular Disease • Ftir • Mass Spectrometry • Pharmacology • Inflammation • Lc Ms • In Vitro • Synthetic Organic Chemistry • Analytical Chemistry • Clinical Development • High Throughput Screening • Protein Chemistry • Drug Metabolism • Pharmacokinetics • Fluorescence • Parallel Synthesis • Drug Delivery • Bioanalysis • Technology Transfer

Industries

Pharmaceuticals

Public records

Vehicle Records

Paul Zinke

View page
Address:
4129 Willow Way Rd, Fort Worth, TX 76133
VIN:
JTMZD33V975040885
Make:
TOYOTA
Model:
RAV4
Year:
2007

Resumes

Resumes

Paul Zinke Photo 1

Principal Scientist, Global Discovery Chemistry

View page
Location:
Dallas, TX
Industry:
Pharmaceuticals
Work:
Novartis Institutes For Biomedical Research (Nibr)
Principal Scientist, Global Discovery Chemistry
Education:
Texas A&M University - Commerce
Master of Science, Masters, Chemistry Texas A&M University - Commerce
Bachelors, Bachelor of Science, Chemistry University of Colorado Boulder
Doctorates, Doctor of Philosophy, Organic Chemistry The University of Texas at Austin
Skills:
Drug Discovery
Lead Change
Medicinal Chemistry
Drug Development
Drug Design
Pharmaceutical Industry
Adme
Hplc
Chemistry
Organic Chemistry
Organic Synthesis
Glp
Gmp
Safety
Process Chemistry
Teaching
Sop
Purification
Nmr
Uv/Vis
Assay Development
Organometallic Chemistry
Cell
Lead Generation
Ocular Disease
Ftir
Mass Spectrometry
Pharmacology
Inflammation
Lc Ms
In Vitro
Synthetic Organic Chemistry
Analytical Chemistry
Clinical Development
High Throughput Screening
Protein Chemistry
Drug Metabolism
Pharmacokinetics
Fluorescence
Parallel Synthesis
Drug Delivery
Bioanalysis
Technology Transfer

Publications

Us Patents

Method Of Prostaglandin Synthesis

View page
US Patent:
6344581, Feb 5, 2002
Filed:
Oct 31, 1997
Appl. No.:
08/962200
Inventors:
Raymond E. Conrow - Crowley TX
Paul W. Zinke - Fort Worth TX
Peter G. Klimko - Fort Worth TX
Robert D. Selliah - Forth Worth TX
Assignee:
Alcon Manufacturing, Ltd. - Fort Worth TX
International Classification:
A61K 31557
US Classification:
560118, 562500
Abstract:
Methods of synthesizing 9-Halo-13,14-dihydroprostaglandins useful in the treatment of glaucoma and ocular hypertension are disclosed. Also disclosed are ophthalmic, pharmaceutical compositions comprising such prostaglandins.

11-Halo Prostaglandins For The Treatment Of Glaucoma Or Ocular Hypertension

View page
US Patent:
6353000, Mar 5, 2002
Filed:
Jun 2, 1999
Appl. No.:
09/284533
Inventors:
Verney L. Sallee - Burleson TX
Mark R. Hellberg - Arlington TX
Peter G. Klimko - Fort Worth TX
Paul W. Zinke - Fort Worth TX
Assignee:
Alcon Laboratories, Inc. - Fort Worth TX
International Classification:
A01N 4316
US Classification:
514310, 549399, 549401, 549429, 560129, 562503
Abstract:
A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I:.

15-Fluoro Prostaglandins As Ocular Hypotensives

View page
US Patent:
6649653, Nov 18, 2003
Filed:
Jun 2, 1999
Appl. No.:
09/284432
Inventors:
Peter G. Klimko - Fort Worth TX
Mark R. Hellberg - Arlington TX
Paul W. Zinke - Fort Worth TX
Assignee:
Alcon Manufacturing, Ltd. - Fort Worth TX
International Classification:
A61K 31216
US Classification:
514530, 514573, 560121, 562503
Abstract:
15-Fluoro substituted analogs of PGF and methods of their use in treating glaucoma and ocular hypertension are disclosed.

15-Fluoro Prostaglandins As Ocular Hypotensives

View page
US Patent:
6680339, Jan 20, 2004
Filed:
Mar 18, 2002
Appl. No.:
10/100399
Inventors:
Peter G. Klimko - Fort Worth TX
Mark R. Hellberg - Highland Village TX
Paul W. Zinke - Fort Worth TX
Assignee:
Alcon Manufacturing, Ltd. - Fort Worth TX
International Classification:
A61K 31216
US Classification:
514530, 514573, 560121, 562503
Abstract:
15-fluoro substituted analogs of PGF and methods of their use in treating glaucoma and ocular hypertension are disclosed.

Use Of Cloprostenol And Fluprostenol Analogues To Treat Glaucoma And Ocular Hypertension

View page
US Patent:
6723748, Apr 20, 2004
Filed:
Feb 5, 2002
Appl. No.:
10/068027
Inventors:
Peter G. Klimko - Fort Worth TX
John E. Bishop - Groton MA
Verney L. Sallee - Burleson TX
Paul W. Zinke - Fort Worth TX
Assignee:
Alcon Manufacturing, Ltd. - Fort-Worth TX
International Classification:
A61K 31215
US Classification:
514530, 514573, 514913
Abstract:
Disclosed is the use of cloprostenol and fluprostenol analogues in combination with carbonic anhydrase inhibitors for the treatment of glaucoma and ocular hypertension and ophthalmic compositions therefor.

5-Hydroxyl Indole Derivatives For Treating Glaucoma

View page
US Patent:
6806285, Oct 19, 2004
Filed:
Sep 5, 2002
Appl. No.:
10/220997
Inventors:
Jesse A. May - Fort Worth TX
Paul W. Zinke - Fort Worth TX
Assignee:
Alcon, Inc. - Hunenberg
International Classification:
A61K 3140
US Classification:
514416, 548470
Abstract:
Novel 3-(2-aminopropyl)-H-indol-5-ols useful for lowering and controlling IOP and treating glaucoma are disclosed.

Hydroxy Substituted Fused Naphthyl-Azoles And Fused Indeno-Azoles And Their Use For The Treatment Of Glaucoma

View page
US Patent:
6884816, Apr 26, 2005
Filed:
Aug 30, 2002
Appl. No.:
10/231699
Inventors:
Jesse A. May - Fort Worth TX, US
Paul W. Zinke - Fort Worth TX, US
Assignee:
Alcon, Inc. - Hunenberg
International Classification:
A61K031/416
C07D231/54
A61P027/00
US Classification:
514405, 5483591
Abstract:
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles are disclosed. Also disclosed are methods for the lowering and controlling of normal or elevated intraocular pressure as well as a method for the treatment of glaucoma using compositions containing one or more of the compounds of the present invention.

Hydroxy Substituted Fused Naphthyl-Azoles And Fused Indeno-Azoles And Their Use For The Treatment Of Glaucoma

View page
US Patent:
6933392, Aug 23, 2005
Filed:
May 28, 2003
Appl. No.:
10/446412
Inventors:
Jesse A. May - Fort Worth TX, US
Paul W. Zinke - Fort Worth TX, US
Assignee:
Alcon, Inc. - Hunenberg
International Classification:
C07D231/54
C07D209/56
US Classification:
5483591, 548427
Abstract:
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles are disclosed. Also disclosed are methods for the lowering and controlling of normal or elevated intraocular pressure as well as a method for the treatment of glaucoma using compositions containing one or more of the compounds of the present invention.
Control profile
Paul W Zinke from Fort Worth, TX, age ~66 Get Report